American Healthcare REIT (NYSE:AHR) Stock Price Expected to Rise, Morgan Stanley Analyst Says

American Healthcare REIT (NYSE:AHR) had its price target hoisted by Morgan Stanley from $36.00 to $37.00 in a research report sent to investors on Tuesday,Benzinga reports. The firm currently has an overweight rating on the stock.

Several other equities analysts have also recently issued reports on the company. Citigroup reissued an “outperform” rating on shares of American Healthcare REIT in a research note on Tuesday, March 4th. Royal Bank of Canada reissued an “outperform” rating and set a $34.00 price objective on shares of American Healthcare REIT in a research report on Wednesday, March 19th. Finally, JMP Securities set a $35.00 target price on shares of American Healthcare REIT in a research report on Tuesday, March 4th. Seven analysts have rated the stock with a buy rating, According to MarketBeat, American Healthcare REIT presently has an average rating of “Buy” and an average target price of $32.17.

American Healthcare REIT Stock Up 0.4 %

Shares of NYSE:AHR opened at $29.95 on Tuesday. The stock’s 50-day moving average is $28.94 and its 200 day moving average is $27.50. The company has a market cap of $4.72 billion and a PE ratio of -62.39. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.37 and a quick ratio of 0.37. American Healthcare REIT has a 1 year low of $12.81 and a 1 year high of $30.97.

American Healthcare REIT Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, April 17th. Stockholders of record on Monday, March 31st will be given a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 3.34%. The ex-dividend date of this dividend is Monday, March 31st. American Healthcare REIT’s dividend payout ratio is presently -370.37%.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. Charles Schwab Investment Management Inc. increased its stake in shares of American Healthcare REIT by 118.4% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,907,986 shares of the company’s stock valued at $49,798,000 after purchasing an additional 1,034,365 shares in the last quarter. Janus Henderson Group PLC grew its stake in shares of American Healthcare REIT by 79.8% in the 3rd quarter. Janus Henderson Group PLC now owns 94,112 shares of the company’s stock worth $2,456,000 after buying an additional 41,755 shares during the last quarter. Swiss National Bank increased its position in American Healthcare REIT by 126.6% during the 3rd quarter. Swiss National Bank now owns 291,400 shares of the company’s stock valued at $7,606,000 after buying an additional 162,800 shares in the last quarter. Geneos Wealth Management Inc. purchased a new position in American Healthcare REIT during the fourth quarter valued at $758,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in American Healthcare REIT by 407.8% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 356,497 shares of the company’s stock worth $9,305,000 after acquiring an additional 286,292 shares in the last quarter. 16.68% of the stock is owned by hedge funds and other institutional investors.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.